Atypical clinical presentation of a subset of patients with anti-RNA polymerase III - non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining

Documenti analoghi

• Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies
  di: Krzyszczak, Malgorzata E., et al.
  Pubblicazione: (2011)
• Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma
  di: Satoh, M, et al.
  Pubblicazione: (2011)
• Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset
  di: Dominguez-Gutierrez, Paul R, et al.
  Pubblicazione: (2014)
• Frequent coexistence of anti-topoisomerase I and anti-U1RNP autoantibodies in African American patients associated with mild skin involvement: a retrospective clinical study
  di: Satoh, Minoru, et al.
  Pubblicazione: (2011)
• Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus
  di: Dominguez-Gutierrez, Paul R, et al.
  Pubblicazione: (2014)